Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Jan;146(1):239–249.

Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.

A A van de Loo 1, O J Arntz 1, A C Bakker 1, P L van Lent 1, M J Jacobs 1, W B van den Berg 1
PMCID: PMC1870767  PMID: 7856731

Abstract

The mechanism underlying the chronic and intermittent course of rheumatoid arthritis is not elucidated. In the present study, the role of interleukin 1 (IL-1) was investigated in exacerbations of antigen-induced arthritis in mice. A flare-up of smoldering inflammation (weeks 3 to 4 of antigen-induced arthritis) was inducible by injection of a small amount of methylated bovine serum albumin into the hypersensitive knee joint. Immunohistochemistry showed IL-1 expression in the synovial lining layer and in focal areas of the inflamed synovium during the flare-up. IL-1 was also measured in 1-hour culture supernatant of synovial tissue taken during the flare-up by a bioassay. The expression of both immunoreactive and bioactive IL-1 in the hypersensitive joint peaked around 6 hours after antigen (2 micrograms of methylated bovine serum albumin) injection and declined thereafter. Antigen rechallenge induced an acute joint swelling of the arthritic joint but not in the naive joint of the sensitized mouse, yet synovia of both joints produced IL-1 after antigen injection. Remarkably, a single intravenous injection of rabbit anti-IL-1 alpha and -beta antibodies 1 hour before antigen rechallenge neutralized IL-1 in the joint. Anti-IL-1 treatment significantly reduced the antigen-induced joint swelling (30 to 40%) but did not affect the profound influx of polymorphonuclear cells in the onset of the exacerbation. However, a profound relief of the inflammation (synovitis) was obtained by IL-1 blockade on day 4 of the exacerbation. Chondrocyte proteoglycan synthesis was markedly suppressed in the antigen-challenged naive knee joints suggesting that this was a direct IL-1 effect as the inflammation was insignificant. Anti-IL-1 treatment was able to maintain chondrocyte proteoglycan synthesis in the antigen-rechallenged joint, which was highly suppressed in the control group. Furthermore, the enhanced proteoglycan breakdown in the antigen-rechallenged joints was significantly decreased in the anti-IL-1 group. We concluded that IL-1 is an important mediator in exacerbations of murine arthritis, and amelioration of cartilage pathology was obtained with anti-IL-1 antibody treatment.

Full text

PDF
239

Images in this article

243Figure 1
on p.243
245Figure 4
on p.245
247Figure 5
on p.247

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arner E. C., Pratta M. A. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum. 1989 Mar;32(3):288–297. doi: 10.1002/anr.1780320310. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. C. The infectious etiology of rheumatoid arthritis. New considerations. Arthritis Rheum. 1978 Jun;21(5):531–538. doi: 10.1002/art.1780210507. [DOI] [PubMed] [Google Scholar]
  3. Blue M. L., Conrad P., Webb D. L., Sarr T., Macaro M. Interacting monocytes and synoviocytes induce adhesion molecules by a cytokine-regulated process. Lymphokine Cytokine Res. 1993 Aug;12(4):213–218. [PubMed] [Google Scholar]
  4. Boots A. M., Wimmers-Bertens A. J., Rijnders A. W. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology. 1994 Jun;82(2):268–274. [PMC free article] [PubMed] [Google Scholar]
  5. Chandrasekhar S., Harvey A. K., Hrubey P. S., Bendele A. M. Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol. 1990 Jun;55(3):382–400. doi: 10.1016/0090-1229(90)90126-b. [DOI] [PubMed] [Google Scholar]
  6. Cicuttini F. M., Martin M., Boyd A. W. Cytokine induction of adhesion molecules on synovial type B cells. J Rheumatol. 1994 Mar;21(3):406–412. [PubMed] [Google Scholar]
  7. Cominelli F., Nast C. C., Clark B. D., Schindler R., Lierena R., Eysselein V. E., Thompson R. C., Dinarello C. A. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest. 1990 Sep;86(3):972–980. doi: 10.1172/JCI114799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deleuran B. W., Chu C. Q., Field M., Brennan F. M., Katsikis P., Feldmann M., Maini R. N. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol. 1992 Dec;31(12):801–809. doi: 10.1093/rheumatology/31.12.801. [DOI] [PubMed] [Google Scholar]
  9. Desmoulins D., Ponteziere C., Agneray J., Ekindjian O. G., Cals M. J. Effects of human recombinant IL-1 beta on rheumatoid and non rheumatoid human synovial cell growth. Cell Mol Biol. 1990;36(3):309–316. [PubMed] [Google Scholar]
  10. Eastgate J. A., Symons J. A., Wood N. C., Grinlinton F. M., di Giovine F. S., Duff G. W. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet. 1988 Sep 24;2(8613):706–709. doi: 10.1016/s0140-6736(88)90185-7. [DOI] [PubMed] [Google Scholar]
  11. Faherty D. A., Claudy V., Plocinski J. M., Kaffka K., Kilian P., Thompson R. C., Benjamin W. R. Failure of IL-1 receptor antagonist and monoclonal anti-IL-1 receptor antibody to inhibit antigen-specific immune responses in vivo. J Immunol. 1992 Feb 1;148(3):766–771. [PubMed] [Google Scholar]
  12. Farahat M. N., Yanni G., Poston R., Panayi G. S. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1993 Dec;52(12):870–875. doi: 10.1136/ard.52.12.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Feldmann M., Brennan F. M., Chantry D., Haworth C., Turner M., Abney E., Buchan G., Barrett K., Barkley D., Chu A. Cytokine production in the rheumatoid joint: implications for treatment. Ann Rheum Dis. 1990 Jun;49 (Suppl 1):480–486. [PubMed] [Google Scholar]
  14. Gearing A. J., Bird C. R., Bristow A., Poole S., Thorpe R. A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods. 1987 May 4;99(1):7–11. doi: 10.1016/0022-1759(87)90025-1. [DOI] [PubMed] [Google Scholar]
  15. Huleihel M., Douvdevani A., Segal S., Apte R. N. Regulation of interleukin 1 generation in immune-activated fibroblasts. Eur J Immunol. 1990 Apr;20(4):731–738. doi: 10.1002/eji.1830200404. [DOI] [PubMed] [Google Scholar]
  16. Issekutz A. C., Meager A., Otterness I., Issekutz T. B. The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin Exp Immunol. 1994 Jul;97(1):26–32. doi: 10.1111/j.1365-2249.1994.tb06574.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jacobs M. J., van den Hoek A. E., van Lent P. L., van de Loo F. A., van de Putte L. B., van den Berg W. B. Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology. 1994 Nov;83(3):390–396. [PMC free article] [PubMed] [Google Scholar]
  18. Kahle P., Saal J. G., Schaudt K., Zacher J., Fritz P., Pawelec G. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis. 1992 Jun;51(6):731–734. doi: 10.1136/ard.51.6.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Klasen I. S., Ladestein R. M., Donselaar I. G., van den Berg W. B., Tees R., Benner R. Joint inflammation in mice induced by a MT4+ Lyt-2- T cell clone. Characteristics and the induction of flare-up reactions. J Immunol. 1987 Nov 15;139(10):3275–3280. [PubMed] [Google Scholar]
  20. Lens J. W., van den Berg W. B., van de Putte L. B., Berden J. H., Lems S. P. Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: effects of pre-treatment with cobra venom factor and anti-lymphocyte serum. Clin Exp Immunol. 1984 Sep;57(3):520–528. [PMC free article] [PubMed] [Google Scholar]
  21. Lewthwaite J., Blake S. M., Hardingham T. E., Warden P. J., Henderson B. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J Rheumatol. 1994 Mar;21(3):467–472. [PubMed] [Google Scholar]
  22. Maeda T., Saikawa I., Hotokebuchi T., Sugioka Y., Eto M., Murakami Y., Nomoto K. Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody. Arthritis Rheum. 1994 Mar;37(3):406–413. doi: 10.1002/art.1780370315. [DOI] [PubMed] [Google Scholar]
  23. Martel-Pelletier J., McCollum R., DiBattista J., Faure M. P., Chin J. A., Fournier S., Sarfati M., Pelletier J. P. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum. 1992 May;35(5):530–540. doi: 10.1002/art.1780350507. [DOI] [PubMed] [Google Scholar]
  24. Mulligan M. S., Ward P. A. Immune complex-induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor-alpha and IL-1. J Immunol. 1992 Jul 1;149(1):331–339. [PubMed] [Google Scholar]
  25. Nakajima H., Hiyama Y., Takamori H., Tsukada W. Cell-mediated transfer of collagen-induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon-gamma and cyclophosphamide. Clin Exp Immunol. 1993 May;92(2):328–335. doi: 10.1111/j.1365-2249.1993.tb03400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nicod L. P., el Habre F., Dayer J. M. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants. Cytokine. 1992 Jan;4(1):29–35. doi: 10.1016/1043-4666(92)90033-n. [DOI] [PubMed] [Google Scholar]
  27. Pettipher E. R., Higgs G. A., Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8749–8753. doi: 10.1073/pnas.83.22.8749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Postigo A. A., García-Vicuña R., Laffón A., Sánchez-Madrid F. The role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Autoimmunity. 1993;16(1):69–76. doi: 10.3109/08916939309010649. [DOI] [PubMed] [Google Scholar]
  29. Sack U., Kuhn H., Ermann J., Kinne R. W., Vogt S., Jungmichel D., Emmrich F. Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J Rheumatol. 1994 Jan;21(1):10–16. [PubMed] [Google Scholar]
  30. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 1986 Aug 7;322(6079):547–549. doi: 10.1038/322547a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schorlemmer H. U., Kanzy E. J., Langner K. D., Kurrle R. Immunomodulatory activity of recombinant IL-1 receptor (IL-1-R) on models of experimental rheumatoid arthritis. Agents Actions. 1993;39(Spec No):C113–C116. doi: 10.1007/BF01972739. [DOI] [PubMed] [Google Scholar]
  32. Schwab J. H., Anderle S. K., Brown R. R., Dalldorf F. G., Thompson R. C. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun. 1991 Dec;59(12):4436–4442. doi: 10.1128/iai.59.12.4436-4442.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schwab J. H., Brown R. R., Anderle S. K., Schlievert P. M. Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol. 1993 May 1;150(9):4151–4159. [PubMed] [Google Scholar]
  34. Shiozawa S., Tanaka Y., Fujita T., Tokuhisa T. Destructive arthritis without lymphocyte infiltration in H2-c-fos transgenic mice. J Immunol. 1992 May 15;148(10):3100–3104. [PubMed] [Google Scholar]
  35. Shore A., Jaglal S., Keystone E. C. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol. 1986 Aug;65(2):293–302. [PMC free article] [PubMed] [Google Scholar]
  36. Stimpson S. A., Esser R. E., Carter P. B., Sartor R. B., Cromartie W. J., Schwab J. H. Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J Exp Med. 1987 Jun 1;165(6):1688–1702. doi: 10.1084/jem.165.6.1688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vivian B., David P., Iancu F., Yoav S., Elimelech O., Peter Y., Tal H., Trevis A. J. The M20 IL-1 inhibitor prevents onset of adjuvant arthritis. Biotherapy. 1992;4(4):317–323. doi: 10.1007/BF02172662. [DOI] [PubMed] [Google Scholar]
  38. Williams R. O., Mason L. J., Feldmann M., Maini R. N. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2762–2766. doi: 10.1073/pnas.91.7.2762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wooley P. H., Whalen J. D., Chapman D. L., Berger A. E., Richard K. A., Aspar D. G., Staite N. D. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum. 1993 Sep;36(9):1305–1314. doi: 10.1002/art.1780360915. [DOI] [PubMed] [Google Scholar]
  40. Yanni G., Whelan A., Feighery C., Quinlan W., Symons J., Duff G., Bresnihan B. Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clin Exp Immunol. 1993 Sep;93(3):387–395. doi: 10.1111/j.1365-2249.1993.tb08190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. van Lent P. L., van den Bersselaar L. A., van den Hoek A. E., van de Loo A. A., van den Berg W. B. Cationic immune complex arthritis in mice--a new model. Synergistic effect of complement and interleukin-1. Am J Pathol. 1992 Jun;140(6):1451–1461. [PMC free article] [PubMed] [Google Scholar]
  42. van Lent P. L., van den Hoek A. E., van den Bersselaar L. A., van de Loo F. A., Eykholt H. E., Brouwer W. F., van de Putte L. B., van den Berg W. B. Early cartilage degradation in cationic immune complex arthritis in mice: relative role of interleukin 1, the polymorphonuclear cell (PMN) and PMN elastase. J Rheumatol. 1994 Feb;21(2):321–329. [PubMed] [Google Scholar]
  43. van de Loo A. A., Arntz O. J., van den Berg W. B. Flare-up of experimental arthritis in mice with murine recombinant IL-1. Clin Exp Immunol. 1992 Feb;87(2):196–202. doi: 10.1111/j.1365-2249.1992.tb02974.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. van de Loo A. A., van den Berg W. B. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis. 1990 Apr;49(4):238–245. doi: 10.1136/ard.49.4.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. van de Loo F. A., Arntz O. J., Otterness I. G., van den Berg W. B. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol. 1992 Mar;19(3):348–356. [PubMed] [Google Scholar]
  46. van den Berg W. B., Joosten L. A., Helsen M., van de Loo F. A. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol. 1994 Feb;95(2):237–243. doi: 10.1111/j.1365-2249.1994.tb06517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. van den Berg W. B., van de Loo F. A., Zwarts W. A., Otterness I. G. Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study. Ann Rheum Dis. 1988 Oct;47(10):855–863. doi: 10.1136/ard.47.10.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. van den Broek M. F., van den Berg W. B., van de Putte L. B. Monoclonal anti-Ia antibodies suppress the flare up reaction of antigen induced arthritis in mice. Clin Exp Immunol. 1986 Nov;66(2):320–330. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES